Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach.

[1]  A. Gabrielli,et al.  European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  M. Worm,et al.  German guidelines for the diagnosis and therapy of localized scleroderma , 2016, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[3]  G. Horneff.  [Development of consensus treatment plans for juvenile localized scleroderma]. , 2014, Zeitschrift fur Rheumatologie.

[4]  Oxford Centre for Evidence-based Medicine Levels of Evidence (January 2001) , 2014 .

[5]  Thomas A Trikalinos,et al.  Simulation-Based Comparison of Methods for Meta-Analysis of Proportions and Rates , 2013 .

[6]  R. Cimaz,et al.  Glucocorticoids in the Management of Systemic Juvenile Idiopathic Arthritis , 2013, Pediatric Drugs.

[7]  H. Jacobe,et al.  Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment. , 2012, Journal of the American Academy of Dermatology.

[8]  Mara Becker,et al.  Development of consensus treatment plans for juvenile localized scleroderma: A roadmap toward comparative effectiveness studies in juvenile localized scleroderma , 2012, Arthritis care & research.

[9]  H. Oliveira,et al.  Low‐dose UVA1 phototherapy for scleroderma: what benefit can we expect? , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[10]  K. Torok.  Pediatric scleroderma: systemic or localized forms. , 2012, Pediatric clinics of North America.

[11]  T. Arkachaisri,et al.  Methotrexate and Corticosteroids in the Treatment of Localized Scleroderma: A Standardized Prospective Longitudinal Single-center Study , 2012, The Journal of Rheumatology.

[12]  M. Cutrone,et al.  Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial. , 2011, Arthritis and rheumatism.

[13]  A. Silman,et al.  Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland , 2010, Arthritis care & research.

[14]  M. Jang,et al.  Efficacy of ultraviolet A1 phototherapy in recalcitrant skin diseases. , 2010, Annals of dermatology.

[15]  D. Veale,et al.  Photochemotherapy for localized morphoea: effect on clinical and molecular markers , 2008, Clinical and experimental dermatology.

[16]  A. Irvine,et al.  Juvenile localised scleroderma: a retrospective review of response to systemic treatment , 2008, Irish journal of medical science.

[17]  A. Paller,et al.  Pediatric morphea (localized scleroderma): review of 136 patients. , 2008, Journal of the American Academy of Dermatology.

[18]  P. Woo,et al.  Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children , 2006, The British journal of dermatology.

[19]  A. Turan,et al.  Parry–Romberg syndrome associated with borreliosis: could photochemotherapy halt the progression of the disease? , 2006, Photodermatology, photoimmunology & photomedicine.

[20]  Y. Kashiwagi,et al.  Therapy of childhood generalized morphea: case reports and reviews of the literature of Japanese cases , 2006, Pediatrics international : official journal of the Japan Pediatric Society.

[21]  P. Woo,et al.  Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. , 2006, Rheumatology.

[22]  J. Burnham,et al.  Treatment of pediatric localized scleroderma with methotrexate. , 2006, The Journal of rheumatology.

[23]  S. Esmat,et al.  Different low doses of broad‐band UVA in the treatment of morphea and systemic sclerosis , 2004, Photodermatology, photoimmunology & photomedicine.

[24]  A. Oikarinen,et al.  Ultraviolet A sunbed used for the treatment of scleroderma. , 2001, Acta dermato-venereologica.

[25]  T. Gambichler,et al.  Combined Treatment with Calcipotriol Ointment and Low‐Dose Ultraviolet A1 Phototherapy in Childhood Morphea , 2001, Pediatric dermatology.

[26]  M. Bosseila,et al.  Low‐dose broad‐band UVA in morphea using a new method for evaluation , 2000, Photodermatology, photoimmunology & photomedicine.

[27]  B. Feldman,et al.  Methotrexate and corticosteroid therapy for pediatric localized scleroderma. , 2000, The Journal of pediatrics.

[28]  J. Sánchez,et al.  Histopathologic differentiation between localized and systemic scleroderma. , 1998, The American Journal of dermatopathology.

[29]  M. Kerscher,et al.  Low-dose UVA phototherapy for treatment of localized scleroderma. , 1998, Journal of the American Academy of Dermatology.

[30]  W. Morison.  Psoralen UVA therapy for linear and generalized morphea. , 1997, Journal of the American Academy of Dermatology.

[31]  T. Ruzicka,et al.  High-dose UVA1 radiation therapy for localized scleroderma. , 1997, Journal of the American Academy of Dermatology.

[32]  S. Gabriel,et al.  The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. , 1997, The Journal of rheumatology.

[33]  M. Kerscher,et al.  Treatment of localised scleroderma by UVA1 phototherapy , 1995, The Lancet.

[34]  V. Falanga.  Fibrosing conditions in childhood. , 1991, Advances in dermatology.